One of the latest advancements in the battle against microbes, HaloShield is a technology that harnesses the antimicrobial power of chlorine-based sanitizers to kill infection-causing pathogens, including MRSA and VRE.
For the first time, hospitals, nursing homes and other healthcare facilities will be able use HaloShield sheets and pillowcases to combat the spread of a wide range of resistant bacteria, viruses and other microbes. This includes MRSA, a form of staph bacteria that is blamed for about 13 percent of the nation’s two million hospital infections each year according to the Centers for Disease Control and Prevention. Overall, hospital infections kill 60,000 to 80,000 people a year at an average annual cost of $6 million per hospital.
HaloShield extends the capabilities of EPA-registered chlorine-based sanitizers — proven hygenic agents that do not promote resistant microbes —to maintain an effective antimicrobial barrier for the lifetime of the sheet.
